Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC (NCT07136285) | Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. | 2023-07-24 |
Track Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.